Home
Topics
Affordable Care Act
COVID-19
Global Health Policy
Health Costs
Health Misinformation and Trust
HIV/AIDS
Medicaid
Medicare
Mental Health
Patient and Consumer Protections
Private Insurance
Racial Equity and Health Policy
Uninsured
Women’s Health Policy
Polling
State Health Facts
State Health Facts
Custom State Reports
KFF Health News
Social Impact Media
Peterson-KFF Health System Tracker
Newsroom
Newsroom
News Releases
Events
Subscribe to Emails
Cite Us/Reprint
Media Contacts
Join Our Team
About Us
About KFF
From Drew Altman
Our People
Our Programs
KFF Board
Contact Us
Support Our Work
Conference Centers
San Francisco, CA
Washington, DC
The independent source for health policy research, polling, and news.
menu
The independent source for health policy research, polling, and news.
Donate
Follow us
Email
Open Search...
Search KFF.org
ACA Open Enrollment
Abortion in the U.S.
Health Policy 101
Charts & Slides
Slides
Slideshows
Home
Charts & Slides
Legal Analysis of the Supreme Court Ruling on Hobby Lobby
Legal Analysis of the Supreme Court Ruling on Hobby Lobby
Published:
Jun 30, 2014
Share this page on Facebook (opens in a new tab)
Share this page on X (opens in a new tab)
Share this page on LinkedIn (opens in a new tab)
Share this page via Email
Print this page
Download Full Power Point
Download Image
Source
Source: Kaiser Family Foundation
Topics
Women's Health Policy
Affordable Care Act
Private Insurance
Tags
Reproductive Health
Courts
Coverage
Employer Health
Prevention
Family Planning
Explore Charts & Slides by Topic
Explore KFF Slides by Topic
Affordable Care Act
Coronavirus (COVID-19)
Global Health Policy
Health Costs
Health Misinformation and Trust
HIV/AIDS
Medicaid
Medicare
Mental Health
Other
Private Insurance
Racial Equity and Health Policy
Uninsured
Women's Health Policy
Search Charts & Slides For:
All charts & slides
Also of Interest
What’s at Stake for Access to Medication Abortion and the FDA in the Supreme Court Case FDA v. the Alliance for Hippocratic Medicine?
Q & A: Implications of Two Conflicting Federal Court Rulings on the Availability of Medication Abortion and the FDA’s Authority to Regulate Drugs
Looking to the Future: Implications of the SCOTUS Ruling on Mifepristone